20 related articles for article (PubMed ID: 9859784)
1. Differential processing of antitumour-active and antitumour-inactive trans platinum compounds by SKOV-3 ovarian cancer cells.
Boccarelli A; Giordano D; Natile G; Coluccia M
Biochem Pharmacol; 2006 Jul; 72(3):280-92. PubMed ID: 16765322
[TBL] [Abstract][Full Text] [Related]
2. In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin.
Bergamo A; Gagliardi R; Scarcia V; Furlani A; Alessio E; Mestroni G; Sava G
J Pharmacol Exp Ther; 1999 Apr; 289(1):559-64. PubMed ID: 10087050
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
[TBL] [Abstract][Full Text] [Related]
4. In vitro antitumour activity and cellular pharmacological properties of the platinum-iminoether complex trans-[PtCl2[E-HN=C(OMe)Me]2].
Coluccia M; Nassi A; Boccarelli A; Giordano D; Cardellicchio N; Intini FP; Natile G; Barletta A; Paradiso A
Int J Oncol; 1999 Nov; 15(5):1039-44. PubMed ID: 10536190
[TBL] [Abstract][Full Text] [Related]
5. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
O'Neill CF; Koberle B; Masters JR; Kelland LR
Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
[TBL] [Abstract][Full Text] [Related]
6. Covalent modification of DNA by antineoplastic agents.
Hemminki K; Ludlum DB
J Natl Cancer Inst; 1984 Nov; 73(5):1021-8. PubMed ID: 6387240
[No Abstract] [Full Text] [Related]
7. Effect of antitumor platinum compounds with trans geometry on the induction of cytotoxicity and cell cycle modifications.
Barletta A; Coluccia M; Nassi A; Pardiso A
Eur J Histochem; 1997; 41 Suppl 2():61-2. PubMed ID: 9859784
[No Abstract] [Full Text] [Related]
8. Current status of structure-activity relationships of platinum anticancer drugs: activation of the trans geometry.
Farrell N
Met Ions Biol Syst; 1996; 32():603-39. PubMed ID: 8640533
[No Abstract] [Full Text] [Related]
9. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
Brabec V; Nováková O
Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
